The data from multiple tumor models under treatment conditions that produced complete tumor eradication highlight a model in which the importance of tumor infiltrating monocyte-derived dendritic cells is critical to maximizing the therapeutic outcome of combined PD-1 and CTLA-4 blockade in lung cancer. The gene discussed is CTLA4; the disease is neoplasm.